» Articles » PMID: 17433638

A Multicenter Italian Study on Pregnancy Outcome in Women with Diabetes

Overview
Publisher Elsevier
Date 2007 Apr 17
PMID 17433638
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: To determine pregnancy outcome in women with type 1 and type 2 diabetes.

Methods And Results: A prospective study was conducted in 33 centers in Italy between 1999 and 2003, mainly recording preterm delivery, stillbirths, neonatal mortality, congenital malformations and birthweight. Of the 668 women examined, 504 had type 1 diabetes and 164 had type 2. Pre-pregnancy counseling had been provided to 43.9% of the women who had type 1 diabetes and 29.1% of the women who had type 2 diabetes and correlated with a better HbA1c value throughout pregnancy. The preterm delivery rate was significantly higher in type 1 and 2 diabetics than in normal pregnant women and was related to HbA1c values higher than 8%, gestational hypertension, pre-eclampsia and the presence of retinopathy before pregnancy. The stillbirth and neonatal mortality rates were also higher in diabetic pregnant women (1.26% and 0.63%, respectively) than in Italian pregnancies in general (0.30% and 0.32%), and the same was true for major congenital malformations (4.9% for diabetic pregnancies, 0.86% for normal Italian pregnancies).

Conclusions: In our population, pregnancy in diabetic women was still associated with a high rate of stillbirths, neonatal mortality and congenital malformations. Unplanned pregnancies and non-optimal glycemia control may help explain the high rates of maternal and neonatal complications.

Citing Articles

A Case Report of a Pregnant Woman With Type 2 Diabetes Mellitus Using Dulaglutide During the First Trimester of Pregnancy.

Alghamdi A, Alsaeddi A, Malki H, Alsaedi A Cureus. 2023; 15(9):e44644.

PMID: 37809127 PMC: 10552061. DOI: 10.7759/cureus.44644.


Trend of pregnancy outcomes in type 1 diabetes compared to control women: a register-based analysis in 1996-2018.

Fazekas-Pongor V, Svebis M, Major D, Partos K, Dosa N, Meszaros A Front Endocrinol (Lausanne). 2023; 14:1232618.

PMID: 37501784 PMC: 10369353. DOI: 10.3389/fendo.2023.1232618.


Correlations between parameters of glycaemic variability and foetal growth, neonatal hypoglycaemia and hyperbilirubinemia in women with gestational diabetes.

Blasi I, Daolio J, Pugni V, Comitini G, Morciano M, Grassi G PLoS One. 2023; 18(3):e0282895.

PMID: 36893129 PMC: 9997917. DOI: 10.1371/journal.pone.0282895.


Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.

Cypryk K, Wender-Ozegowska E, Cyganek K, Sieradzki J, Skoczylas K, Chen X Acta Diabetol. 2023; 60(4):553-561.

PMID: 36653533 PMC: 10033617. DOI: 10.1007/s00592-022-02020-9.


Risk of birth defects by pregestational type 1 or type 2 diabetes: National Birth Defects Prevention Study, 1997-2011.

Marchincin S, Howley M, Van Zutphen A, Fisher S, Nestoridi E, Tinker S Birth Defects Res. 2022; 115(1):56-66.

PMID: 35665489 PMC: 10582790. DOI: 10.1002/bdr2.2050.